Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Cancer Letters
|
July 6, 2011
Preoperative analysis of 11q loss using circulating tumor-released DNA in serum: a novel diagnostic tool for therapy stratification of neuroblastoma
Shigeki Yagyu, Tomoko Iehara, Takahiro Gotoh, et al.
Japanese Journal of Clinical Oncology
|
March 12, 2013
Ewing sarcoma arising after treatment of diffuse large B-cell lymphoma
Nobuhiro Hiramoto, Yukio Kobayashi, Junko Nomoto, et al.
Molecular Cancer Therapeutics
|
May 19, 2025
A novel conditionally replicative oncolytic adenovirus under the control of the SALL4 promoter inhibits the growth of rhabdoid tumors
Satoru Oya, Hideki Yoshida, Akimasa Tomida, et al.
Cancer Science
|
April 21, 2026
Bispecific Ligand-Based EphB4 CAR-T Cells Generated Using Ephrin-B2 Show Potent Antitumor Activity Against Lung Adenocarcinoma
Hirotaka Kumeda, Koichi Hirabayashi, Shuji Mishima, et al.
Pediatric Blood & Cancer
|
July 26, 2019
Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee
Tomoko Iehara, Akihiro Yoneda, Isao Yokota, et al.
Biochemical and Biophysical Research Communications
|
August 30, 2011
Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression
Yoshiki Katsumi, Tomoko Iehara, Mitsuru Miyachi, et al.
Molecular Cancer Therapeutics
|
August 28, 2020
The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of <i>NOXA</i>
Yohei Sugimoto, Yoshiki Katsumi, Tomoko Iehara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
Circulating methylated-DCR2 gene in serum as an indicator of prognosis and therapeutic efficacy in patients with MYCN nonamplified neuroblastoma
Shigeki Yagyu, Takahiro Gotoh, Tomoko Iehara, et al.
Plos One
|
August 12, 2016
Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma
Shigeki Yagyu, Tomoko Iehara, Shiro Tanaka, et al.
Clinical & Translational Immunology
|
May 12, 2021
Mutated GM-CSF-based CAR-T cells targeting CD116/CD131 complexes exhibit enhanced anti-tumor effects against acute myeloid leukaemia
Aiko Hasegawa, Shoji Saito, Shogo Narimatsu, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Cancer Letters
|
July 6, 2011
Preoperative analysis of 11q loss using circulating tumor-released DNA in serum: a novel diagnostic tool for therapy stratification of neuroblastoma
Shigeki Yagyu, Tomoko Iehara, Takahiro Gotoh, et al.
Japanese Journal of Clinical Oncology
|
March 12, 2013
Ewing sarcoma arising after treatment of diffuse large B-cell lymphoma
Nobuhiro Hiramoto, Yukio Kobayashi, Junko Nomoto, et al.
Molecular Cancer Therapeutics
|
May 19, 2025
A novel conditionally replicative oncolytic adenovirus under the control of the SALL4 promoter inhibits the growth of rhabdoid tumors
Satoru Oya, Hideki Yoshida, Akimasa Tomida, et al.
Cancer Science
|
April 21, 2026
Bispecific Ligand-Based EphB4 CAR-T Cells Generated Using Ephrin-B2 Show Potent Antitumor Activity Against Lung Adenocarcinoma
Hirotaka Kumeda, Koichi Hirabayashi, Shuji Mishima, et al.
Pediatric Blood & Cancer
|
July 26, 2019
Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee
Tomoko Iehara, Akihiro Yoneda, Isao Yokota, et al.
Biochemical and Biophysical Research Communications
|
August 30, 2011
Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression
Yoshiki Katsumi, Tomoko Iehara, Mitsuru Miyachi, et al.
Molecular Cancer Therapeutics
|
August 28, 2020
The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of <i>NOXA</i>
Yohei Sugimoto, Yoshiki Katsumi, Tomoko Iehara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
Circulating methylated-DCR2 gene in serum as an indicator of prognosis and therapeutic efficacy in patients with MYCN nonamplified neuroblastoma
Shigeki Yagyu, Takahiro Gotoh, Tomoko Iehara, et al.
Plos One
|
August 12, 2016
Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma
Shigeki Yagyu, Tomoko Iehara, Shiro Tanaka, et al.
Clinical & Translational Immunology
|
May 12, 2021
Mutated GM-CSF-based CAR-T cells targeting CD116/CD131 complexes exhibit enhanced anti-tumor effects against acute myeloid leukaemia
Aiko Hasegawa, Shoji Saito, Shogo Narimatsu, et al.
Page
of 7